Published November 21, 2017 | Version v1
Journal article Open

Favorable Biological Responses of Neural Cells and Tissue Interacting with Graphene Oxide Microfibers

  • 1. Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (HNP-SESCAM), Finca La Peraleda s/n, 45071 Toledo, Spain
  • 2. Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (HNP-SESCAM), Finca La Peraleda s/n, 45071 Toledo, Spain; Research Unit of "Design and Development of Biomaterials for Neural Regeneration", Hospital Nacional de Parapléjicos (HNP-SESCAM), Joint Research Unit with CSIC, 45071 Toledo, Spain
  • 3. Materials Science Factory, Instituto de Ciencia de Materiales de Madrid, Consejo Superior de Investigaciones Científicas (ICMM-CSIC), Calle Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain

Description

Neural tissue engineering approaches show increasing promise for the treatment of neural diseases including spinal cord injury, for which an efficient therapy is still missing. Encouraged by both positive findings on the interaction of carbon nanomaterials such as graphene with neural components and the necessity of more efficient guidance structures for neural repair, we herein study the potential of reduced graphene oxide (rGO) microfibers as substrates for neural growth in the injured central neural tissue. Compact,
bendable, and conductive fibers are obtained. When coated with neural adhesive molecules (poly-L-lysine and N-cadherin), these microfibers behave as supportive substrates of highly interconnected cultures composed of neurons and glial cells for up to 21 days. Synaptic contacts close to rGO are identified. Interestingly, the colonization by meningeal fibroblasts is dramatically hindered by N-cadherin coating. Finally, in vivo studies reveal the feasible implantation of these rGO microfibers as a guidance platform in the injured rat spinal cord, without evident signs of subacute local toxicity. These positive findings boost further investigation at longer implantation times to prove the utility of these substrates as components of advanced therapies for enhancing repair in the damaged central neural tissue including the injured spinal cord.

Files

BYAXON_GonzalezMayorga_ACSOmega_2017.pdf

Files (1.9 MB)

Name Size Download all
md5:e5d79eea055f0ebff575c51a24801bde
1.9 MB Preview Download

Additional details

Funding

European Commission
ByAxon – Towards an active bypass for neural reconnection 737116